Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
Hampel PJ, Rabe KG, Call TG, Ding W, Leis JF, Chanan-Khan AA, Kenderian SS, Muchtar E, Wang Y, Ailawadhi S, Koehler AB, Parrondo R, Schwager SM, Sher T, Hanson CA, Shi M, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA.
Hampel PJ, et al. Among authors: kenderian ss.
Blood Cancer J. 2022 Sep 1;12(9):124. doi: 10.1038/s41408-022-00721-6.
Blood Cancer J. 2022.
PMID: 36050317
Free PMC article.